BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27807828)

  • 1. ANXA7-GTPase as Tumor Suppressor: Mechanisms and Therapeutic Opportunities.
    Leighton X; Eidelman O; Jozwik C; Pollard HB; Srivastava M
    Methods Mol Biol; 2017; 1513():23-35. PubMed ID: 27807828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas.
    Yadav AK; Renfrow JJ; Scholtens DM; Xie H; Duran GE; Bredel C; Vogel H; Chandler JP; Chakravarti A; Robe PA; Das S; Scheck AC; Kessler JA; Soares MB; Sikic BI; Harsh GR; Bredel M
    JAMA; 2009 Jul; 302(3):276-89. PubMed ID: 19602687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of annexin A7 in cancers.
    Guo C; Liu S; Greenaway F; Sun MZ
    Clin Chim Acta; 2013 Aug; 423():83-9. PubMed ID: 23639634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SEC-induced activation of ANXA7 GTPase suppresses prostate cancer metastasis.
    Liu S; Li X; Lin Z; Su L; Yan S; Zhao B; Miao J
    Cancer Lett; 2018 Mar; 416():11-23. PubMed ID: 29247827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells.
    Torosyan Y; Simakova O; Naga S; Mezhevaya K; Leighton X; Diaz J; Huang W; Pollard H; Srivastava M
    Int J Cancer; 2009 Dec; 125(11):2528-39. PubMed ID: 19610065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANXA7 expression represents hormone-relevant tumor suppression in different cancers.
    Srivastava M; Torosyan Y; Raffeld M; Eidelman O; Pollard HB; Bubendorf L
    Int J Cancer; 2007 Dec; 121(12):2628-36. PubMed ID: 17708571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription.
    Torosyan Y; Dobi A; Naga S; Mezhevaya K; Glasman M; Norris C; Jiang G; Mueller G; Pollard H; Srivastava M
    Cancer Res; 2006 Oct; 66(19):9609-16. PubMed ID: 17018618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of multi-hnRNP nuclear complex in regulation of tumor suppressor ANXA7 in prostate cancer cells.
    Torosyan Y; Dobi A; Glasman M; Mezhevaya K; Naga S; Huang W; Paweletz C; Leighton X; Pollard HB; Srivastava M
    Oncogene; 2010 Apr; 29(17):2457-66. PubMed ID: 20190808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse effects of ANXA7 and p53 on LNCaP prostate cancer cells are associated with regulation of SGK1 transcription and phosphorylation of the SGK1 target FOXO3A.
    Srivastava M; Leighton X; Starr J; Eidelman O; Pollard HB
    Biomed Res Int; 2014; 2014():193635. PubMed ID: 24864229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Dominant-Negative Mutant of ANXA7 Impairs Calcium Signaling and Enhances the Proliferation of Prostate Cancer Cells by Downregulating the IP3 Receptor and the PI3K/mTOR Pathway.
    Srivastava M; Bera A; Eidelman O; Tran MB; Jozwik C; Glasman M; Leighton X; Caohuy H; Pollard HB
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A7 is correlated with better clinical outcomes of patients with breast cancer.
    Huang Y; Wang H; Yang Y
    J Cell Biochem; 2018 Sep; 119(9):7577-7584. PubMed ID: 29893423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma.
    Tokunaga E; Oki E; Kimura Y; Yamanaka T; Egashira A; Nishida K; Koga T; Morita M; Kakeji Y; Maehara Y
    Breast Cancer Res Treat; 2007 Mar; 101(3):249-57. PubMed ID: 17006756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin-protein ligase E3C promotes glioma progression by mediating the ubiquitination and degrading of Annexin A7.
    Pan SJ; Zhan SK; Ji WZ; Pan YX; Liu W; Li DY; Huang P; Zhang XX; Cao CY; Zhang J; Bian LG; Sun B; Sun QF
    Sci Rep; 2015 Jun; 5():11066. PubMed ID: 26067607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue microarray analysis delineate potential prognostic role of Annexin A7 in prostate cancer progression.
    Leighton X; Bera A; Eidelman O; Bubendorf L; Zellweger T; Banerjee J; Gelmann EP; Pollard HB; Srivastava M
    PLoS One; 2018; 13(10):e0205837. PubMed ID: 30321230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MROH7-TTC4 read-through lncRNA suppresses vascular endothelial cell apoptosis and is upregulated by inhibition of ANXA7 GTPase activity.
    He X; Zhao X; Su L; Zhao B; Miao J
    FEBS J; 2019 Dec; 286(24):4937-4950. PubMed ID: 31408583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
    Festuccia C; Angelucci A; Gravina GL; Biordi L; Millimaggi D; Muzi P; Vicentini C; Bologna M
    Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High ANXA7 Potentiates Eucalyptol Toxicity in Hormone-refractory Prostate Cancer.
    Leighton X; Bera A; Eidelman O; Eklund M; Puthillathu N; Pollard HB; Srivastava M
    Anticancer Res; 2018 Jul; 38(7):3831-3842. PubMed ID: 29970503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
    Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA
    Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways.
    Xing C; Ci X; Sun X; Fu X; Zhang Z; Dong EN; Hao ZZ; Dong JT
    Neoplasia; 2014 Nov; 16(11):883-99. PubMed ID: 25425963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a small molecule targeting annexin A7.
    Li H; Liu N; Wang S; Wang L; Zhao J; Su L; Zhang Y; Zhang S; Xu Z; Zhao B; Miao J
    Biochim Biophys Acta; 2013 Sep; 1833(9):2092-9. PubMed ID: 23651924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.